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Abstract
Background: Honey bees (Apis mellifera) have recently experienced higher than normal overwintering colony losses. Many
factors have been evoked to explain the losses, among which are the presence of residues of pesticides and veterinary
products in hives. Multiple residues are present at the same time, though most often in low concentrations so that no single
product has yet been associated with losses. Involvement of a combination of residues to losses may however not be
excluded. To understand the impact of an exposure to combined residues on honey bees, we propose a mechanism-based
strategy, focusing here on Multi-Drug Resistance (MDR) transporters as mediators of those interactions.
Methodology/Principal Findings: Using whole-animal bioassays, we demonstrate through inhibition by verapamil that the
widely used organophosphate and pyrethroid acaricides coumaphos and t-fluvalinate, and three neonicotinoid insecticides:
imidacloprid, acetamiprid and thiacloprid are substrates of one or more MDR transporters. Among the candidate inhibitors
of honey bee MDR transporters is the in-hive antibiotic oxytetracycline. Bees prefed oxytetracycline were significantly
sensitized to the acaricides coumaphos and t-fluvalinate, suggesting that the antibiotic may interfere with the normal
excretion or metabolism of these pesticides.
Conclusions/Significance: Many bee hives receive regular treatments of oxytetracycline and acaricides for prevention and
treatment of disease and parasites. Our results suggest that seasonal co-application of these medicines to bee hives could
increase the adverse effects of these and perhaps other pesticides. Our results also demonstrate the utility of a mechanism-
based strategy. By identifying pesticides and apicultural medicines that are substrates and inhibitors of xenobiotic
transporters we prioritize the testing of those chemical combinations most likely to result in adverse interactions.
Citation: Hawthorne DJ, Dively GP (2011) Killing Them with Kindness? In-Hive Medications May Inhibit Xenobiotic Efflux Transporters and Endanger Honey
Bees. PLoS ONE 6(11): e26796. doi:10.1371/journal.pone.0026796
Editor: Guy Smagghe, Ghent University, Belgium
Received December 3, 2010; Accepted October 4, 2011; Published November 2, 2011
Copyright:  2011 Hawthorne, Dively. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by the United States Department of Agriculture. The funders had no role in study design, data collection and analysis,
decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: djh@umd.edu
Introduction
Honey bees are in trouble. Widespread depopulation of colonies
often characterized by high overwintering losses has occurred
since at least 2006 in the United States, threatening the
sustainability of North American apiculture. Despite considerable
effort, no single cause of the phenomenon called colony collapse
disorder (CCD) has been identified, though associations of several
pathogens and parasites appear to increase the risk of colony
collapse [1,2]. Pesticides are also among the suspected contribut-
ing factors of colony collapse both because bees encounter a
diverse array of pesticides when foraging and because more than
120 different pesticides have been found within bee hives
[2,3,4,5,6]. Some pesticides have received extra scrutiny, notably
the acaricides coumaphos and t-fluvalinate, applied to bee hives
for control of parasitic varroa mites, and the widely used
neonicotinoid insecticides. These acaricides are applied directly
to bee hives, accumulate in wax and were found in nearly all hives
recently tested in both N. American and France [5,6]. The
neonicotinoids (especially imidacloprid) are of concern because
they are toxic to honey bees, used on many crops and ornamental
plants, and they tend to be systemically distributed within treated
plants, potentially contaminating nectar and pollen of treated and
rotational crops not initially treated with these products [7,8,9,10].
Although pesticide drift and overdosing cause accidental bee
kills no single pesticide has been directly implicated with
widespread overwintering losses or CCD [2,5]. It remains possible
however, that combinations of toxins may cause adverse additive
or synergistic effects that would be difficult to detect through
surveys of beekeepers or analysis of their apiaries without
dedicated multifactorial analysis. It has been shown, for example,
that the toxicity to bees of some pyrethroid and neonicotinoid
insecticides increases significantly when combined with certain
fungicides [11,12]. Similarly, Johnson et al. [13] found that
coumaphos and t-fluvalinate each synergize the other’s toxicity to
honey bees, perhaps through competitive inhibition of the
metabolic enzymes that detoxify those pesticides. Given the many
pesticides that bees encounter there may be adverse combinations
of them eroding hive health in both subtle and dramatic ways.
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adverse pesticide combinations which prevents evaluation of all, or
even most, combinations of them. This problem challenges our
ability to anticipate the risks associated with bee’s exposure to a
novel pesticide or to identify combinations of toxins contributing
to a colony collapse. If we could identify mechanisms of the honey
bee xenobiotic metabolism and excretion systems that systemat-
ically mediate multiple-toxin interactions, we could reduce the
overwhelming number of candidate pesticide interactions to a
smaller set of compounds that are substrates or inhibitors of the
most predictive mechanisms.
The membrane-bound transporter proteins from the ABC
transporter family of proteins are found in all phyla [14,15]. The
xenobiotic transporters in this family actively shuttle toxins across
cell membranes to reduce the intracellular toxin and metabolite
concentrations. Working in concert with metabolic enzymes, these
transporters mediate a baseline tolerance to a diverse array of
toxins including numerous drugs, pesticides and phytochemicals
[16,17]. Several of these transporters, especially members of the
ABCB, ABCC, and ABCG subfamilies of transporters (referred to
here as Multiple Drug Resistance, or MDR transporters), are of
medical importance, playing a role in resistance to multiple cancer
and anti-parasite drugs [17,18,19].
MDR transporters are relatively unstudied in insects, and
completely neglected in honey bee toxicology. These transporters
act in several insect tissues, including the cuticle [20], malpighian
tubules [21,22], midgut [23] and at the blood-brain barrier
[24,25] to transport toxins, including pesticides, towards excretion
[17]. The honey bee genome contains genes coding for
orthologues of these proteins, which presumably protect bees
from toxins as they do in Drosophila melanogaster [24,26,27],
chironomid flies [28], mosquitoes [29], Heliothis virescens (tobacco
budworm) [20] and Manduca sexta (tomato hornworm) [21,25]. It
seems reasonable therefore to consider the role that these proteins
play in honey bee tolerance of pesticides and to begin an analysis
of potentially inhibitory compounds that bees commonly encoun-
ter.
The most well studied MDR transporter, p-glycoprotein (p-gp),
has both a diverse range of substrates and is inhibited by an array
of drugs, pesticides and plant compounds [17]. This inhibition is a
mechanism by which MDR transporters would cause adverse
interactions among many chemicals; one compound inhibits the
transporters thereby increasing sensitivity to other toxic substrates.
The drug verapamil is a potent inhibitor of p-gp and possibly other
MDR transporters [30,31]. It is frequently used as the standard
inhibitor of p-gp where it increases the sensitivity of treated cells,
tissues or organisms to toxic transporter substrates [17,18,26].
Here we use verapamil inhibition to determine if 5 pesticides are
substrates of MDR transporters and therefore potentially syner-
gized by other inhibitors more likely to be encountered by honey
bees. Remarkably, three widely used in-hive pesticides and
medications (the previously mentioned acaricides coumaphos
and t-fluvalinate and the antibiotic oxytetracycline) are known
substrates and/or inhibitors of mammalian p-gp [31,32,33]. We
suspect that these in-hive medications and pesticides may be
interacting with bee’s MDR transporters, increasing their
sensitivity to these and perhaps other pesticides and toxins. The
frequent contamination of hive wax with these acaricides [6] and
routine treatment of hives with oxytetracycline [34,35,36,37]
undoubtedly increases the exposure of bees to these compounds,
with potentially significant consequences if they are indeed
substrates or inhibitors of honey bee MDR transporters.
Interaction of neonicotinoid insecticides with insect MDR
transporters has not yet been reported. Because of the likelihood
of exposure of bees to these insecticides we ask if the neonicotinoid
insecticides imidacloprid, acetamiprid and thiacloprid are sub-
strates of honey bee MDR transporters. Evidence of neonicotinoid
processing by MDR transporters would be significant because
inhibition of those transporters could cause mortality at lower
doses than normally expected for individual compounds.
Results
When fed to bees verapamil significantly increased the toxicity
of all 5 acaricides/insecticides. Mean mortality of young worker
bees topically treated with the acaricides coumaphos or t-
fluvalinate was significantly higher when bees were pretreated
with verapamil (Fig. 1, Table 1). Control mortality following
topical application of acetone was 0% for both sucrose and
sucrose+verapamil fed bees. Acute oral toxicity was also
significantly higher for all three neonicotinoids (acetamiprid,
thiacloprid, imidacloprid) when bees were pretreated with
verapamil (Fig. 1, Table 2). Increased mortality at higher
concentrations and at the later end point (48 h) was observed
for thiacloprid, and at 48 h for imidacloprid. The effect of
verapamil pretreatment did not differ among concentrations of
these insecticides (Table 2). Control mortality of sucrose only and
sucrose+verapamil cohorts averaged 2–3%.
Oxytetracycline significantly increased the mortality of bees
exposed to coumaphos and t-fluvalinate (Fig. 2). For comparison
with the verapamil synergism reported above, mean mortality of
bees treated with 2 ug/ul coumaphos increased from 7% (n=4
cages) to 51% (n=4 cages) following feeding of OTC (1.4 mM), a
significant but smaller increase than that caused by verapamil
(Fig. 2A,Table 1). OTC feeding increased the mortality of bees
treated with 3 ug/ul t-fluvalinate from 5.6% (n=10 cages) to 39%
(n=8 cages) (Fig. 2B, p=0.002). Mean mortality of cohorts fed
OTC alone were below 10% and were not significantly different
from those fed sucrose alone (Fig. 2).
Discussion
Here we provide the first evidence that the MDR transporter(s)
inhibited by verapamil play a role in protecting honey bees from
pesticides, and that the acaricides coumaphos and t-fluvalinate,
and 3 neonicotinoid insecticides are substrates of these transporters
in insects. The observation that coumaphos and t-fluvalinate are
substrates of honey bee p-gp or another MDR transporter was
anticipated from previous study of mouse cells, and suggests that
insect and mammalian MDR transporters share substrates.
Clearly, the abundance of these pesticides found in the wax and
pollen of bee hives [6] coupled with evidence that their toxicity to
bees is increased through inhibition of MDR transporters
implicates them as toxins of interest in any multifactorial
explanation of high overwintering colony losses.
This is the first report that neonicotinoid insecticides are
substrates of insect MDR transporters. In efforts to protect honey
bees, energetic opposition to the neonicotinoids has arisen in
North America and Europe, but direct implication of them in
overwintering losses has not been sustained by recent research
[2,6]. Estimates of the environmental exposure of bees to
imidacloprid are typically low relative to the LD50 [6], and studies
have not demonstrated hive-level consequences of imidacloprid
contamination [38]. Our results suggest that inhibition of MDR
transporters may reduce the LD50 of neonicotinoids possibly
amplifying acute and chronic effects to bees at lower concentra-
tions.
The large increases in sensitivity to pesticides by inhibition of
MDR transporters and the chemical diversity of the synergized
MDR-Transporters and Synergism of Pesticides
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synergisms of diverse toxins in bees. Because of its clinical
importance in human health, proven and candidate p-gp
substrates and inhibitors of many types have been identified
[16,17]. Knowledge of these compounds may help us identify
chemicals likely to interact with honey bee MDR transporters. In
the first application of this mechanism-based strategy to honey
bees, we uncover a significant negative interaction among three
medications routinely applied to bee hives [35,36,37]. OTC,
coumaphos and t-fluvalinate are all known to interact with
mammalian p-gp [31,32,33]. If honey bee transporters behave
similarly, we would expect increased toxicity following co-
application of a toxic transporter substrate and an inhibitor. As
anticipated, concentrations of OTC similar to those applied to
bee hives increased bee’s sensitivity to both coumaphos and t-
fluvalinate. OTC is applied to bee hives in the late fall and/or
early spring, often in tandem with one of the acaricides [36]. Our
results suggest that co-application of these compounds could
increase the likelihood of intoxication by the acaricides and other
pesticides contaminating beeswax and food stores. These results
raise the possibility that adverse interactions of medications (such
as OTC) and pesticides (coumaphos and t-fluvalinate) contribute
to the loss of honey bee colonies during the winter or early spring,
a common feature of CCD. Although the per-bee concentration
of OTC used here is similar to field application rates, the
pesticide concentrations are higher than those found in bee hives
(see [6]). Therefore, although we have demonstrated that
verapamil and OTC increase bee’s sensitivity to these pesticides
in acute laboratory bioassays, additional testing of lower pesticide
concentrations over longer time periods is necessary to fully
understand the field relevance of these interactions. Additional
work is also required to directly demonstrate that OTC inhibits
p-gp or other efflux transporters in honey bees. Nevertheless, we
show here using OTC and the acaricides as an example, how
identification of MDR transporter substrates and inhibitors can
highlight potentially dangerous chemical combinations and
improve the assessment and management of toxicological risks
faced by honey bees.
Figure 1. Verapamil synergizes honey bee mortality by five acaricides/insecticides. Mean mortality (6SE) of honey bees (average of 24
and 48 h) following topical (A, B) and oral (C, D, E) exposure to pesticides. Bees were pre-fed sucrose or sucrose+verapamil (1 mM) solution. For each
pesticide, different letters indicate significant differences between treatments (p,0.05).
doi:10.1371/journal.pone.0026796.g001
Table 1. Repeated-measures analysis of variance of honey bee mortality.
Pesticide treatment (Pretreatment)
Coumaphos (Verapamil) t-Fluvalinate (Verapamil) Coumaphos (OTC)
df F p df F p df F p
Pretreatment 1,14.5 61.89 ,0.0001 1,10 57.77 ,0.0001 1,11 10.83 0.0072
Time 1,11.2 3.91 0.07 1,10 1.46 0.26 1,9.8 10.64 0.0088
Pretreatment6Time 1,11.2 3.20 0.10 1,10 1.46 0.26 1,9.8 1.66 0.2277
Bees were pretreated with verapamil, oxytetracycline (OTC), or sucrose syrup then treated with the acaricides coumaphos or t-fluvalinate.
doi:10.1371/journal.pone.0026796.t001
MDR-Transporters and Synergism of Pesticides
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Insects
Bees were collected for laboratory bioassays from newly
established colonies reared on new frames and freshly drawn
comb. Colonies were not treated with apicultural medications or
pesticides. Frames with emerging workers were taken from hives
and placed into dark growth chambers maintained at 3362uC and
(70–80%) RH. Newly-emerged bees were collected from the
frames daily and maintained in groups of 20–30 in 806100 mm
metal mesh cages capped at each end by standard polystyrene
petri dishes. Bees were fed sucrose solution (50%; w:v) through
1 mm holes from a 2.0 ml microfuge tube.
Chemicals
Terramycin (oxytetracycline, 5.5% soluble powder, Pfizer) was
purchased from Dadant and Sons (Hamilton, Illinois). Couma-
phos, t-fluvalinate (both technical grade) and verapamil were
purchased from Sigma-Aldrich Inc. (St. Louis, MO). Commercial
formulations of imidacloprid (Admire Pro) and thiacloprid
(Calypso) were provided by Bayer CropScience (Durham, NC),
and acetamiprid (Assail) was provided by United Phosphorous Inc.
(King of Prussia, PA).
Drug pretreatments
Verapamil (1 mM) and oxytetracycline (OTC, 1.4 mM) were
incorporated into 50% sucrose solutions for oral dosing of 1–3 day
Table 2. Repeated-measures analysis of variance of honey bee mortality.
Imidacloprid Acetamiprid Thiacloprid
df F p df F p df F p
Pretreatment 1,28 17.78 0.0002 1,12 128.54 ,0.0001 1,24 65.53 ,0.0001
Concentration 1,28 2.75 0.11 1,12 0.26 0.62 1,24 27.93 ,0.0001
Time 1,28 43.12 ,0.0001 1,12 1.24 0.29 1,24 94.97 ,0.0001
Pretreatment6Concentration 1,28 0.80 0.38 1,12 0.27 0.61 1,24 2.39 0.11
Pretreatment6Time 1,28 1.72 0.2 1,12 0.63 0.44 1,24 53.31 ,0.0001
Concentration6Time 1,28 0.66 0.42 1,12 1.02 0.33 1,24 58.17 ,0.0001
Pre6Conce6Time 1,28 3.51 0.07 1,12 0.80 0.39 1,24 69.75 ,0.0001
Bees were pretreated with verapamil or sucrose syrup and then fed one of three neonicotinoid insecticides.
doi:10.1371/journal.pone.0026796.t002
Figure 2. Oxytetracycline (OTC) synergizes honey bee mortality by in-hive acaricides. Mean mortality (6SE) of honey bees pre-fed sucrose
solution (50%) or sucrose+oxytetracycline (1.4 mM) and topical application of (A) coumaphos (average of 24 and 48 h) and (B) t-fluvalinate (24 h). For
each pesticide, different letters indicate significant differences between treatments (p,0.05).
doi:10.1371/journal.pone.0026796.g002
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verapamil revealed no toxicity. The 1.4 mM concentration of
OTC provides a per-bee exposure comparable to that of the label-
recommended dosage of 600 mg applied to a hive containing
12,000 bees—a typical colony size entering winter [39]. Sucrose-
drug solutions were made fresh every 3 days and the vials
supplying each cage were replaced as needed.
Topical bioassays of insecticides/acaricides
Cohorts of 3–6 day old workers pretreated by feeding with the
two sucrose-drug solutions were anesthetized with CO2, and 1 ul
of coumaphos (2 ug/ul)or t-fluvalinate (3 ug/ul) in acetone (or
acetone alone for controls) was applied to the dorsal thorax of each
bee using an ISCO microapplicator driving a 1/4 cc tuberculin
syringe. After application, bees were returned to cages containing
the sucrose-drug or sucrose-only solution. Mortality of bees in each
cage was recorded at 24 and 48 h. 5–10 replicate cohorts of 25
bees were tested for each acaricide - pretreatment combination.
Oral bioassays of insecticides
Pre-fed cohorts of 3–6 day old workers were fed sucrose syrup
containing one of the neonicotinoids. Mortality of each cage was
recorded at 24 and 48 hours. Imidacloprid was tested at 5 and
50 ng/ul, acetamiprid at 25 and 100 ng/ul, and thiacloprid at 25,
100 and 500 ng/ul. These concentrations caused low-intermediate
mortality of bees fed sucrose-only solution in preliminary range-
finding experiments. 2–13 replicate cohorts of 25 bees were tested
for each toxin concentration - pretreatment combination.
Analysis. The effects of verapamil or OTC pretreatment on
insecticide/acaricide mortality were tested using a repeated
measures analysis of variance (Proc Mixed, SAS). Following
transformation (arcsine square-root), mortality was analyzed with
a model that included pretreatment, insecticide concentration if
multiple levels were used, and time endpoints (24 and 48 h) as
fixed factors to assess the main effects and their interactions.
Because only mortality at 24 h was available, analysis of t-
fluvalinate combined with OTC, was performed using a simple t-
test, comparing the t-fluvalinate and the t-fluvalinate+OTC
treatments.
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